Table 1.
Mean age (SD, range) | 61.6 | (10.1, 35.5–86.0) |
Mean BMI (SD, range) | 27.8 | (5.2, 19.1–44.7) |
Race [N (%)] | ||
White | 31 | (63.3%) |
Black or African American | 9 | (18.4%) |
Asian | 5 | (10.2%) |
Other | 1 | (2%) |
Unknown | 3 | (6.1%) |
Chemotherapy [N (%)] | ||
Taxane-based only | 44 | (89.8%) |
Taxane and platinum combined | 5 | (10.2%) |
Time (year) from Chemotherapy Completion (Median, Range) | 3 | (0.26–18) |
Mean subjective measures (SD, Range) | ||
NRS pain | 4.2 | (2.6, 0–8) |
NRS numbness | 5.7 | (2.3, 0–10) |
NRS tingling | 4.4 | (2.7, 0–10) |
NPS | 41.0 | (22.4, 0–84) |
FACT/GOG-Ntx | 25.8 | (6.8, 8–40) |